Wei Heng
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 7
- CAR-T cell therapy research 2
- Lung Cancer Research Studies 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Aiping Tong (3 shared papers)Shasha Zhao (2 shared papers)Zongliang Zhang (2 shared papers)Limin Yang (2 shared papers)Chunhua Ling (2 shared papers)Gang Guo (2 shared papers)Meijia Yang (2 shared papers)Liangxue Zhou (2 shared papers)
In The Last Decade
Wei Heng
18 papers receiving 309 citations
Peers
Comparison fields: 5 of 41
- Oncology 175
- Immunology 87
- Cancer Research 34
- Immunology and Allergy 9
- Genetics 40
Countries citing papers authored by Wei Heng
This map shows the geographic impact of Wei Heng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Heng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Heng more than expected).
Fields of papers citing papers by Wei Heng
This network shows the impact of papers produced by Wei Heng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Heng. The network helps show where Wei Heng may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Heng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 147 | |
| 2 | 2020 | 47 | |
| 3 | 2018 | 28 | |
| 4 | 2017 | 18 | |
| 5 | 2017 | 17 | |
| 6 | 2013 | 15 | |
| 7 | 2001 | 7 | |
| 8 | 2020 | 7 | |
| 9 | 2022 | 4 | |
| 10 | 2024 | 4 | |
| 11 | 2023 | 4 | |
| 12 | 2011 | 4 | |
| 13 | CIST System Report for ACL MultiLing 2013 -- Track 1: Multilingual Multi-document Summarization | 2013 | 3 |
| 14 | 2012 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2015 | 1 | |
| 19 | 2025 | 0 |
About Wei Heng
Wei Heng is a scholar working on Oncology, Molecular Biology, Electrical and Electronic Engineering, Computer Networks and Communications and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 311 indexed citations. Recurring topics across this work include Cooperative Communication and Network Coding (2 papers), Advanced Wireless Network Optimization (2 papers), CAR-T cell therapy research (2 papers), Lung Cancer Research Studies (2 papers), Peptidase Inhibition and Analysis (2 papers), Wireless Communication Networks Research (1 paper), Neurofibromatosis and Schwannoma Cases (1 paper) and Advanced MIMO Systems Optimization (1 paper). The work is most often cited by research in Oncology (175 citations), Immunology (87 citations), Cancer Research (34 citations), Immunology and Allergy (9 citations) and Genetics (40 citations). Wei Heng has collaborated with scholars based in China, Malaysia and Pakistan. Frequent co-authors include Aiping Tong, Shasha Zhao, Zongliang Zhang, Limin Yang, Chunhua Ling, Gang Guo, Meijia Yang, Liangxue Zhou, Xin Tang and Caiying Jiang. Their work appears in journals such as Biotechnology Letters, Oncotarget, Journal of Thoracic Oncology, Frontiers in Immunology and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.